Month: December 2018

Buying Medibank at $2.31 was a high conviction idea expressed on the blog, we now see the stock consolidating near $2.50.

We recommend selling covered call options to enhance the income return.

MPL goes ex-div $0.055 on the 6th of March.

For more detail on the strategy, please call our office on 1300 614 002

Sonic Healthcare is under Algo Engine buy conditions and is a current holding within the ASX 100 model portfolio.

SHL has strengthened its US footprint with the purchase of Aurora Diagnostics for US$540m, (A$750m), mainly funded with up to a A$700m equity raise.

The placement is priced at A$19.50/share, an 8.8% discount to the last
close price.

FY19 revenue $6.2bn, EBITDA $1.1bn, net profit $5.30mn, EPS $1.22, DPS$0.90 places Sonic on a forward yield of 4.5%

We recommend buying Sonic Healthcare and selling a covered call option to enhance the income.

US stocks have slipped, continuing their declines from a day earlier, as a batch of disappointing earnings reports added to the gloom.

With the S&P500 closing at 2467 it is now within 100 points of completing a 20% sell-off from the 2018 highs. 2350 = 20% correction  and 2100 =  30% correction.

If we consider the 50% range of the 2009 low to the 2018 high for the S&P500, it would pencil out to 1820  points. This would be a very significant level of support.

Oil Search is a current holding in the ASX 100 model portfolio.

With the oil price retracing into our targeted consolidation range, we’re now accumulating both Oil Search and Woodside shares.

OSH – Buy $6.25 – $6.75

WPL – Buy $29 – $30.50

BHP delivered 44.67% return over 659 days including dividends.

Below is a copy of our Model Portfolio email instructions showing BHP being closed from our ASX 100 model portfolio following yesterday’s Algo Engine sell signal.

To sign up for the portfolio adjustment instructions, please visit

https://blog.investorsignals.com/

Or call 1300 614 002

Unibail-Rodamco-Westfield is the premier global developer and operator of flagship shopping destinations, with a portfolio valued at €63.7 Bn, (as at 30 June 18).

86% of the portfolio is in retail, 8% in offices, 5% in convention & exhibition
venues and 1% in services.

Currently, the Group owns and operates 97 shopping centres, including 56 flagships in the most dynamic cities in Europe and the United States. Its’ centres welcome 1.2 billion visits per year. Present on 2 continents and in 13 countries.

The Group has the largest development pipeline in the industry, worth €12.5 Bn.

Unibail-Rodamco-Westfield stapled shares are listed on Euronext Amsterdam and Euronext Paris (Euronext ticker: URW), with a secondary listing in Australia through Chess Depositary Interests.

The Group benefits from an A rating from Standard & Poor’s and from an A2 rating from Moody’s.

After selling Unibail at $14.50 per share, immediately following the takeover in June, we now have this name back on our radar.

NOTE: Further to an agreement entered into in October 2018, Unibail-Rodamco-Westfield announces the completion of the disposal of the Tour Ariane office building, located in the heart of La Défense business
district, (Paris region), to Singapore’s sovereign wealth fund GIC. The Net Disposal Price of the transaction is €464.9 million.